Segall Judith Insider Trades

Insider Trading History

Track insider trading activity for Segall Judith. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
AgeX Therapeutics
AgeX Therapeutics AGE
Director Of Admin & Secretary
Holding Value $33.3k 3,000 shares
Last Trade
Jun 04, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.35k 3,000 shares
$1.45
$11.10
AgeX Therapeutics
AgeX Therapeutics AGE
Director, Admin & Secretary
Holding Value $167k 15,000 shares
Last Trade
Nov 19, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$21.6k 15,000 shares
$1.44
$11.10
AgeX Therapeutics
AgeX Therapeutics AGE
Corporate Secretary
Holding Value $0 0 shares
Last Trade
Nov 27, 2018 Sale
No data
No data
$11.10
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Vice President & Secretary
Holding Value $30.3k 25,000 shares
Last Trade
Jan 20, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$62.5k 25,000 shares
$2.50
$1.21
OncoCyte
OncoCyte 0KCC.L
Corporate Secretary
Holding Value $0 0 shares
Last Trade
Dec 30, 2015 Sale
No data
No data
$6.41
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Vice President & Secretary
Holding Value $60.5k 50,000 shares
Last Trade
Mar 03, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$183k 50,000 shares
$3.65
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Vice President & Secretary
Holding Value $60.5k 50,000 shares
Last Trade
Mar 20, 2014 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$152k 50,000 shares
$3.03
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Vice President & Secretary
Holding Value $60.5k 50,000 shares
Last Trade
Feb 20, 2013 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$182k 50,000 shares
$3.65
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Vice President & Secretary
Holding Value $623k 514,645 shares
Last Trade
Nov 22, 2011 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$21.5k 5,770 shares
$3.72
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Vice President & Secretary
Holding Value $720k 594,645 shares
Last Trade
Nov 22, 2011 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$298k 80,000 shares
$3.72
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Vice President & Secretary
Holding Value $0 0 shares
Last Trade
Nov 22, 2011 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$298k 80,000 shares
$3.72
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Vice President & Secretary
Holding Value $630k 520,415 shares
Last Trade
Nov 23, 2010 Sale (Open Market)Shares sold on the open market or in a private sale.
$14.2k 2,128 shares
$6.68
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Vice President & Secretary
Holding Value $632k 522,543 shares
Last Trade
Nov 22, 2010 Sale (Open Market)Shares sold on the open market or in a private sale.
$116k 17,400 shares
$6.67
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Vice President & Secretary
Holding Value $653k 539,943 shares
Last Trade
Nov 19, 2010 Sale (Open Market)Shares sold on the open market or in a private sale.
$48.6k 7,600 shares
$6.39
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Vice President & Secretary
Holding Value $663k 547,543 shares
Last Trade
Nov 05, 2010 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$653k 125,000 shares
$5.23
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Vice President & Secretary
Holding Value $511k 422,543 shares
Last Trade
Nov 05, 2010 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$210k 40,125 shares
$5.23
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Vice President & Secretary
Holding Value $0 0 shares
Last Trade
Nov 05, 2010 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$653k 125,000 shares
$5.23
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Vice President & Secretary
Holding Value $0 0 shares
Last Trade
Nov 01, 2010 Sale (In The Money)Reported as In The Money on SEC Form 4.
$125k 21,586 shares
$5.77
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Vice President & Secretary
Holding Value $560k 462,668 shares
Last Trade
Nov 01, 2010 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$125k 21,586 shares
$5.77
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Vice President & Secretary
Holding Value $0 0 shares
Last Trade
Aug 18, 2010 Sale (In The Money)Reported as In The Money on SEC Form 4.
$129k 23,750 shares
$5.43
$1.21

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up